Business Context and Reporting Period
This Form 8-K Current Report is filed by Curis, Inc. (Delaware) with a report date of September 23, 2004, and a signature date of November 18, 2004. The filing addresses a material definitive agreement entered into on September 23, 2004, and a subsequent corporate governance issue regarding the independence of the Audit Committee discovered in November 2004.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial data disclosed relates to a consulting transaction:
- Consulting Fee Rate: $2,000 per day or $250 per hour.
- Fee Cap: $50,000 total under the agreement.
- Payment Made: $14,000 paid to Dr. Joseph M. Davie on September 23, 2004.
Material Changes and Events
Consulting Agreement: The Company entered into a consulting agreement with Dr. Joseph M. Davie, a Board member, effective February 2, 2004. The agreement covers business development and drug development services, including evaluation of IND packages and intellectual property. The initial term is one year, terminable with 30 days' notice.
Audit Committee Independence Violation: In November 2004, the Company notified NASDAQ that the Audit Committee failed to meet independence requirements under Rule 4350(d)(2)(A)(ii) and Rule 10A-3(b)(ii)(a). The violation stemmed from the $14,000 consulting payment made to Dr. Davie, a member of the Audit Committee, which was deemed impermissible.
Remedial Action: The Board of Directors replaced Dr. Davie on the Audit Committee with Mr. James R. McNab, a current Board member believed to meet independence requirements.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future financial performance. The primary risk disclosed is the failure to satisfy NASDAQ continued listing rules regarding Audit Committee independence, which was triggered by the improper compensation of a committee member.
Investor Verification Checklist
- Verify the status of the $14,000 payment to Dr. Davie (whether it was returned or reclassified).
- Confirm the current composition and independence status of the Audit Committee following the appointment of Mr. McNab.
- Review the full text of the Consulting Agreement (Exhibit 10.1) for additional terms not summarized in the 8-K.
- Check for any subsequent correspondence from NASDAQ regarding the delisting notice or compliance plan.